UK drug marketing code violations fall

13 July 2008

The UK's Prescription Medicines Code of Practice Authority, which enforces the Association of the British Pharmaceutical Industry's marketing rules, has reported a small reduction in the number of complaints about the promotion of prescription drugs, from 128 in 2006 to 122 last year. Violations of the Code were ruled in 61% or less of cases considered in 2007 and 2006. This compares favorably with 2005 where 80% of the 107 complaints were upheld. There was also a decrease in time taken to consider cases in 2007 compared with 2006.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight